Phaedon Zavras

246 posts

Phaedon Zavras banner
Phaedon Zavras

Phaedon Zavras

@pdzavras

Med Onc Attending, Breast Medicine Service @MSKCancerCenter | Through: @hopkinskimmel @EinsteinMed @uoaofficial 🇬🇷

New York, NY Katılım Mart 2019
792 Takip Edilen614 Takipçiler
Phaedon Zavras retweetledi
Komal Jhaveri, MD, FACP, FASCO
Komal Jhaveri, MD, FACP, FASCO@jhaveri_komal·
Super timely as FDA approved Dato in 1L metastatic TNBC for those who are not PD-1/PDL-1 I candidates based on the phase 3 TB-02 trial today!
Annals of Oncology@Annals_Oncology

🆕 Article in press: Dato-DXd combo with durvalumab as 1L treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from the phase Ib/II BEGONIA study annalsofoncology.org/article/S0923-…

English
2
20
56
10.2K
Phaedon Zavras retweetledi
Sarah Premji, MD
Sarah Premji, MD@SPremji7866·
Always so happy to see my favorite newly minted faculty! Representing USCF, UCLA, MSK and SCRI - we met as 2nd yr fellows and get to reunite at these meetings - lucky to grow with these incredible individuals! @AlexisLeVee @pdzavras @KelseyNatsuhara @SABCSSanAntonio
Sarah Premji, MD tweet media
English
0
3
26
1.2K
Phaedon Zavras retweetledi
Johns Hopkins Hematology and Oncology Fellowship
Johns Hopkins Hematology and Oncology Fellowship@Hopkins_HemOnc·
🎓Congratulations to our outstanding @hopkinskimmel oncology fellows on their graduation! We're so proud of all you've accomplished and excited to see the impact you’ll make in the field. Here's to the next chapter!
Johns Hopkins Hematology and Oncology Fellowship tweet media
English
1
2
37
2.1K
Phaedon Zavras retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
54
498
1.5K
480.3K
Phaedon Zavras retweetledi
Tatiana Prowell, MD
Tatiana Prowell, MD@tmprowell·
#ASCO25 #OncTwitter #crcsm NEW: Randomized trial of exercise vs health ed in people w/ colon cancer post adjuvant chemo: disease-free (HR 0.72; 6.4% abs diff at 5y) & overall (HR 0.63; 7.1% abs diff at 8y) survival improved w/ exercise! NNT ~14. ACTUALLY tolerable. 🏆 #OncoAlert
Tatiana Prowell, MD tweet media
English
1
23
57
5.6K
Phaedon Zavras
Phaedon Zavras@pdzavras·
Always a joy to reunite with this phenomenal group of breast oncologists! Huge congratulations to all on the well-deserved YIAs—and a big thank you to @ConquerCancerFd and @ASCO for their continued support of early-career investigators. #ASCO25
Phaedon Zavras tweet media
English
0
4
13
1K
Phaedon Zavras retweetledi
Kristen A. Marrone, MD
Kristen A. Marrone, MD@kamarroneMD·
Congratulations to our 🌟 @Hopkins_HemOnc fellows Drs. Ferreira, Liang, Mo, Walsh and Zavras on their @ASCO @ConquerCancerFd Young Investigator Awards. And to our alumna/phenomenal faculty member @marinabaretti on her CDA! So incredibly proud of their hard work & dedication 🤩🙌🏼
Kristen A. Marrone, MD tweet mediaKristen A. Marrone, MD tweet mediaKristen A. Marrone, MD tweet media
English
0
5
20
1.2K
Phaedon Zavras retweetledi
Christine Hodgdon
Christine Hodgdon@christeeny513·
In 2022, @JaniceTNBCmets , @corrie_painter, & I sat together to hear the much anticipated DESTINY-Breast 04 trial results. As cancer survivors, when we see data, we see the patients behind the data, we ARE the patients behind the data, & we’re grateful to still be here! #ASCO25
Christine Hodgdon tweet media
English
5
8
61
1.4K
Karun Neupane, MD
Karun Neupane, MD@KarunNeupaneMD·
Excited for this year's #ASCO25!! Looking forward to presenting our team's work, meeting colleagues and learning from leaders in the field. Thanks to @ConquerCancerFd for the support!
Karun Neupane, MD tweet mediaKarun Neupane, MD tweet mediaKarun Neupane, MD tweet media
Karun Neupane, MD@KarunNeupaneMD

Happy #ASCO25 abstract results day!! Excited for this oral presentation of our work from ASCO IMG CoP including 15+ IMGs. Huge thanks to my team members & mentors @DrChoueiri @ArdeshirFatemeh @CharlesJiangMD @royaryam @NazliDizman @ZiadBakouny @IMG_Oncologists @MoffittNews

English
1
2
20
1.3K
Phaedon Zavras
Phaedon Zavras@pdzavras·
I am thrilled to receive the 2025 @ASCO / @ConquerCancerFd Young Investigator Award! I am deeply grateful to my mentors at @hopkinskimmel @Hopkins_HemOnc for their unwavering support and guidance throughout three transformative years of fellowship.
Johns Hopkins Hematology and Oncology Fellowship@Hopkins_HemOnc

Congratulations to all, including our very own YIA awardees Drs. Ferreira, Liang, Mo, Walsh, and Zavras AND a well deserved CDA to alum Dr. Baretti! @pdzavras @KaiLiangMD @MFerreiraMD @marinabaretti

English
9
1
51
5.2K

Keşfet

@AlexisLeVee @KelseyNatsuhara @SABCSSanAntonio @KaiLiangMD @ASCO @AACR @sepideh_gholami @manjuggm